Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
Hall
M Craig
MC
American Urological Association Education and Research, Inc., USA. Craig.Hall@cornerstonehealthcare.com
Chang
Sam S
SS
Dalbagni
Guido
G
Pruthi
Raj Som
RS
Seigne
John Derek
JD
Skinner
Eila Curlee
EC
Wolf
J Stuart
JS
Schellhammer
Paul F
PF
D000283:Administration, Intravesical; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D015653:Cystectomy / Q000379:methods; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*
D001500:BCG Vaccine